Physician profile
Amanda S Hahn
NPI 1437310612
$1,770.00
in general payments reported to CMS, 2019-2025
24 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $90.47 · 2021: $118 · 2022: $60.72 · 2023: $336 · 2024: $290 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $331.93 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $206.08 | 2019-2025 | Collagenase Santyl |
| Next Science LLC | $203.02 | 2023-2024 | Blastx, Xperience, Surgx |
| Organogenesis INC. | $175.27 | 2020-2024 | Puraply |
| Mimedx Group, INC. | $150.14 | 2024-2025 | |
| Davol INC. | $132.26 | 2019-2025 | Phasix Mesh |
| Acell, INC. | $118.60 | 2019 | |
| Convatec INC. | $57.23 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $42.31 | 2019-2025 | Nuzyra |
| Solventum Corporation | $39.88 | 2024-2025 | Promogran Prisma, Kerramax Care, V.A.C. Dermatac |
| Allergan, INC. | $39.42 | 2019-2020 | |
| Kci USA, INC. | $37.70 | 2019-2023 | Prevena |
| Amgen INC. | $30.27 | 2025 | Krystexxa |
| Myriad Genetic Laboratories, INC. | $27.55 | 2025 | Myrisk |
| Integra Lifesciences Corporation | $23.17 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.81 | 2025 | |
| Medtronic, INC. | $19.87 | 2025 | Ligasure |
| Vertex Pharmaceuticals Incorporated | $19.72 | 2025 | |
| Hartmann USA, INC. | $17.86 | 2023 | Zetuvit Plus |
| W. L. Gore & Associates, INC. | $16.94 | 2022 | |
| Medtronic Vascular, INC. | $15.83 | 2019 | |
| Urgo Medical North America, LLC | $14.36 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Orpyx Medical Technologies US INC. | $13.93 | 2022 | |
| Tactile Systems Technology INC | $13.85 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.